Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells

Abstract

Pixantrone (PIX) is an anticancer drug approved for the treatment of multiple relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma. It is an aza-anthracenedione synthesized to have the same anticancer activity as its predecessors, anthracyclines (e.g. doxorubicin) and anthracenediones (e.g. mitoxantrone), with lower cardiotoxicity. However, published data regarding its possible cardiotoxicity are scarce. Therefore, this work aimed to assess the potential cytotoxicity of PIX, at clinically relevant concentrations (0.1; 1; and 10 μM) in both non-differentiated and 7-day differentiated H9c2 cells. Cells were exposed to PIX for 48 h and cytotoxicity was evaluated through phase contrast microscopy, Hoescht staining and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction and neutral red (NR) uptake assays. Cytotoxicity was observed in differentiated and non-differentiated H9c2 cells, with detached cells and round cells evidenced by phase contrast microscopy, mainly at the highest concentration tested (10 μM). In the Hoechst staining, PIX 10 μM showed a marked decrease in the number of cells when compared to control but with no signs of nuclear condensation. Furthermore, significant concentration-dependent mitochondrial dysfunction was observed through the MTT reduction assay. The NR assay showed similar results to those obtained in the MTT reduction assay in both differentiated and non-differentiated H9c2 cells. The differentiation state of the cells was not crucial to PIX effects, although PIX toxicity was slightly higher in differentiated H9c2 cells. To the best of our knowledge, this was the first in vitro study performed with PIX in H9c2 cells and it discloses worrying cytotoxicity at clinically relevant concentrations.

In Vitro Models for Cancer-Associated Cachexia: The Complex Modelling of a Multiorgan Syndrome

“…So, it is necessary to keep in mind that further passages of cardiomyocytes may not ensure the repeatability and reliability of the results because of the ageing culture [64]. The cell line is remarkably interesting in cytotoxic studies to analyse the cardiotoxicity safety of anticancer drugs namely, Doxorubicin [67], Mitoxantrone [68] and Pixantrone [69], focusing also on the mechanisms of myocyte damage and effect on cell apoptosis and necrosis.…”

Ginsenoside Rg1 protects H9c2 cells against nutritional stress‐induced injury via aldolase /AMPK/PINK1 signalling

“…Hoechst staining was performed, as previously described. 18 Cells were examined in a fluorescence microscope (Ts2R, Nikon, Japan).…”

GC-MS Analysis and In-vitro Apoptosis Induction and Anticancer Activity of Methanol Extract of Aspergillus terreusagainst Lung Cancer

“…4 The chemotherapeutic drugs used today to treat cancer give patient's temporary relief and lengthen their lives, but they also have drawbacks like side effects, lack of selectivity, and high prices that not only lower patients' quality of life but are also out of reach for millions of patients in developing countries. 5 In the past, natural products have achieved tremendous advancements in the field of anti-cancer research; more than 60% of anti-cancer medications used in clinical trials now come from natural sources, such as plants and microorganisms. 6 N a t u ra l p ro d u c t s p ro d u c e d b y microorganisms offer a wide range of potential novel medicinal compounds.…”